SBP solbec pharmaceuticals limited

a bit too much excitement?

  1. JWM
    319 Posts.
    There has been a lot of optimism expressed on this stock in the past few days which may be unjustified. Yes, I will accept that the announcement was good, but it should be assessed in light of the fact they have yet to go to phase one trials. This means that returns to the share holders could be years off.

    If you are to make money, trade on its volatility as it goes in and out of the various phases prescribed by law, but it is for punters only.

    Personnally, I would worry about any company that has difficulty deciding whether it is a miner or a biotech
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.